GLP1R agonists like lixisenatide, exenatide, or semaglutide limit the progression of motor dysfunction in Parkinson’s disease.
Eli Lilly
Posted inAutoimmune Diseases, Metabolism, New Drugs, Regulatory
Awiqli: Basal Insulin Once a Week
Novo Nordisk invented insulin icodec, a very patient-friendly ultra-long-acting insulin.
Posted inAutoimmune Diseases, Clinical Trials
Apogee Therapeutics: Treating Eczema With Two Injections per Year
Biologic treatment for atopic dermatitis reaches a new level of convenience.
Posted inClinical Trials, Metabolism
Dorzagliatin: Drug That Can “Cure” Diabetes
Hua Medicine has figured out how to bring type 2 diabetes mellitus into long-term and sustained remission.
Posted inAutoimmune Diseases, New Drugs, Regulatory
Sotyktu: Miracle Pill for Autoimmune Diseases
Deucravacitinib by Bristol-Myers Squibb can help with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and systemic lupus erythematosus.
Posted inCOVID-19, Infections, Research
Omicron Treatment: Most Effective Drugs
Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
Posted inClinical Trials, In the Pipeline, Metabolism
Most Effective Weight Loss Drugs: Present and Future
Modern pharmacological ways to combat obesity.